Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2006) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 | Signal | journal | 0.102 Q4 | 1 | 7 | 22 | 192 | 0 | 10 | 0.00 | 27.43 |  |
| 144 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.103 Q4 | 8 | 0 | 31 | 0 | 1 | 28 | 0.07 | 0.00 | |
| 143 | EBR - European Biopharmaceutical Review | journal | 0.107 Q4 | 6 | 76 | 198 | 344 | 5 | 175 | 0.03 | 4.53 | |
| 142 | European Journal of Herbal Medicine | journal | 0.107 Q4 | 3 | 0 | 8 | 0 | 0 | 3 | 0.00 | 0.00 | |
| 141 | Journal of Applied Therapeutic Research | journal | 0.107 Q4 | 8 | 5 | 47 | 96 | 8 | 47 | 0.24 | 19.20 | |
| 140 | Pharmaceutical Medicine | journal | 0.107 Q4 | 25 | 42 | 94 | 1075 | 10 | 71 | 0.07 | 25.60 | |
| 139 | EPC - European Pharmaceutical Contractor | journal | 0.110 Q4 | 3 | 85 | 301 | 191 | 4 | 253 | 0.02 | 2.25 | |
| 138 | Quality Assurance Journal | journal | 0.127 Q4 | 11 | 26 | 97 | 222 | 13 | 85 | 0.17 | 8.54 | |
| 137 | Journal of Drug Evaluation | journal | 0.130 Q4 | 5 | 0 | 45 | 0 | 6 | 19 | 0.13 | 0.00 | |
| 136 | DARU, Journal of Pharmaceutical Sciences | journal | 0.157 Q4 | 58 | 40 | 96 | 1102 | 29 | 96 | 0.27 | 27.55 | |
| 135 | Drug Discovery Today: Disease Models | journal | 0.177 Q4 | 33 | 63 | 112 | 2356 | 35 | 107 | 0.31 | 37.40 | |
| 134 | Journal of Generic Medicines (discontinued) | journal | 0.181 Q3 | 16 | 45 | 101 | 418 | 17 | 85 | 0.19 | 9.29 | |
| 133 | Current Drug Discovery | journal | 0.188 Q3 | 13 | 0 | 227 | 0 | 60 | 123 | 0.27 | 0.00 | |
| 132 | Pharmacy in Practice | journal | 0.189 Q3 | 6 | 52 | 198 | 414 | 12 | 165 | 0.06 | 7.96 | |
| 131 | Cutaneous and Ocular Toxicology | journal | 0.205 Q4 | 37 | 25 | 71 | 946 | 27 | 69 | 0.45 | 37.84 | |
| 130 | IDrugs : the investigational drugs journal | journal | 0.205 Q3 | 39 | 177 | 645 | 886 | 320 | 639 | 0.52 | 5.01 | |
| 129 | Drug Discovery World | journal | 0.220 Q4 | 14 | 28 | 48 | 243 | 28 | 43 | 0.58 | 8.68 | |
| 128 | Toxicology Mechanisms and Methods | journal | 0.220 Q3 | 55 | 67 | 131 | 2826 | 87 | 130 | 0.59 | 42.18 | |
| 127 | Paediatric and Perinatal Drug Therapy | journal | 0.225 Q3 | 20 | 29 | 43 | 639 | 27 | 36 | 0.74 | 22.03 | |
| 126 | Toxicology and Industrial Health | journal | 0.231 Q3 | 69 | 47 | 69 | 1780 | 67 | 69 | 0.92 | 37.87 | |
| 125 | Drug Discovery Today: Disease Mechanisms | journal | 0.242 Q4 | 28 | 74 | 146 | 3305 | 74 | 134 | 0.51 | 44.66 | |
| 124 | Toxin Reviews | journal | 0.242 Q3 | 54 | 29 | 90 | 1716 | 84 | 83 | 0.96 | 59.17 | |
| 123 | Pharmaceutical Journal | journal | 0.245 Q2 | 28 | 1077 | 7669 | 1200 | 257 | 612 | 0.03 | 1.11 | |
| 122 | International Journal of Pharmacy Practice | journal | 0.250 Q2 | 44 | 43 | 98 | 1125 | 58 | 98 | 0.54 | 26.16 | |
| 121 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.251 Q2 | 8 | 44 | 8 | 1133 | 5 | 8 | 0.63 | 25.75 | |
| 120 | Journal of Liposome Research | journal | 0.281 Q2 | 64 | 34 | 53 | 1012 | 67 | 49 | 1.28 | 29.76 | |
| 119 | Immunopharmacology and Immunotoxicology | journal | 0.305 Q3 | 61 | 56 | 158 | 1721 | 141 | 156 | 0.80 | 30.73 | |
| 118 | Pharmaceutical Biology | journal | 0.310 Q2 | 88 | 118 | 388 | 2997 | 238 | 385 | 0.47 | 25.40 | |
| 117 | Autonomic and Autacoid Pharmacology | journal | 0.313 Q3 | 24 | 66 | 70 | 1548 | 60 | 70 | 0.58 | 23.45 | |
| 116 | International Journal of Cosmetic Science | journal | 0.314 Q2 | 77 | 45 | 91 | 1419 | 80 | 91 | 0.68 | 31.53 | |
| 115 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.319 Q3 | 100 | 69 | 51 | 6961 | 76 | 51 | 1.49 | 100.88 | |
| 114 | ATLA Alternatives to Laboratory Animals | journal | 0.320 Q3 | 65 | 58 | 348 | 1745 | 285 | 321 | 0.77 | 30.09 | |
| 113 | Advances in Antiviral Drug Design | book series | 0.327 Q2 | 12 | 0 | 7 | 0 | 9 | 7 | 0.00 | 0.00 | |
| 112 | American Journal of Drug Delivery | journal | 0.329 Q3 | 23 | 28 | 41 | 1319 | 36 | 39 | 0.88 | 47.11 | |
| 111 | Drug Design and Discovery | journal | 0.329 Q3 | 20 | 0 | 12 | 0 | 16 | 12 | 0.00 | 0.00 | |
| 110 | Comments on Toxicology | journal | 0.335 Q3 | 13 | 0 | 12 | 0 | 6 | 10 | 0.00 | 0.00 | |
| 109 | ChemMedChem | journal | 0.341 Q2 | 119 | 145 | 441 | 5995 | 562 | 439 | 1.18 | 41.34 | |
| 108 | Journal of Negative Results in BioMedicine | journal | 0.346 Q1 | 25 | 19 | 23 | 696 | 22 | 23 | 1.00 | 36.63 | |
| 107 | Journal of Food Biochemistry | journal | 0.351 Q3 | 64 | 49 | 107 | 1685 | 86 | 106 | 0.76 | 34.39 | |
| 106 | Drug Discovery Today: Therapeutic Strategies | journal | 0.359 Q3 | 31 | 86 | 129 | 3896 | 117 | 122 | 0.91 | 45.30 | |
| 105 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.362 Q3 | 54 | 117 | 314 | 2136 | 233 | 313 | 0.74 | 18.26 | |
| 104 | Biopharmaceutics and Drug Disposition | journal | 0.364 Q2 | 65 | 50 | 142 | 1523 | 178 | 142 | 1.24 | 30.46 | |
| 103 | Pharmaceutical Statistics | journal | 0.371 Q3 | 46 | 34 | 63 | 499 | 41 | 53 | 0.65 | 14.68 | |
| 102 | Drugs in R and D | journal | 0.377 Q3 | 54 | 37 | 190 | 1816 | 244 | 190 | 1.49 | 49.08 | |
| 101 | Chemical Speciation and Bioavailability | journal | 0.388 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 100 | BMC Chemical Biology | journal | 0.400 Q3 | 21 | 3 | 6 | 90 | 7 | 6 | 1.40 | 30.00 | |
| 99 | SAR and QSAR in Environmental Research | journal | 0.411 Q3 | 54 | 37 | 111 | 1616 | 235 | 111 | 2.27 | 43.68 | |
| 98 | Clinical Toxicology | journal | 0.412 Q3 | 108 | 83 | 317 | 1846 | 491 | 255 | 1.52 | 22.24 | |
| 97 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.433 Q3 | 81 | 87 | 230 | 2306 | 320 | 215 | 1.20 | 26.51 | |
| 96 | Journal of Chemotherapy | journal | 0.444 Q3 | 56 | 167 | 400 | 3355 | 614 | 367 | 1.51 | 20.09 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data